The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

“This epidemic, no doubt, was fueled by Purdue Pharma’s manufacturing and deceptive ... Consulting firm McKinsey, which was accused of helping Purdue boost its OxyContin sales, recently ...

If approved, over 30 million documents related to Purdue Pharma’s opioid business would be made public ... Johnson & Johnson, Mallinckrodt, McKinsey, Teva, Walgreens and Walmart settlements. The first ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

NEW YORK: McKinsey & Co is beefing up its ethics department after a series of high-profile controversies, including helping Purdue Pharma LP “turbocharge” opioid sales. The management ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

FILE - The Purdue Pharma offices are seen, May 8, 2007, in Stamford, Conn. (AP Photo/Douglas Healey, File) FILE - The Purdue Pharma offices are seen, May 8, 2007, in Stamford, Conn. (AP Photo ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York ...